Cameroon vs El Salvador: Access to anti-retroviral drugs, male
Cameroon
79.0%
in 2024
El Salvador
78.0%
in 2024
Cameroon rank
49th
El Salvador rank
51st
Access to anti-retroviral drugs, male over time
- Cameroon
- El Salvador
How they compare
Cameroon currently reports 79.0% against 78.0% in El Salvador, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was El Salvador ahead.
Cameroon ranks 49th and El Salvador ranks 51st of 141 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.7% | 13.1% | 8.4% | El Salvador |
| 2010s | 26.0% | 50.7% | 24.7% | El Salvador |
| 2020s | 68.2% | 75.4% | 7.2% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cameroon or El Salvador?
- Cameroon, at 79.0% against 78.0% in El Salvador as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cameroon and El Salvador?
- 1.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and El Salvador?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and El Salvador rank globally for access to anti-retroviral drugs, male?
- Cameroon ranks 49th and El Salvador ranks 51st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.